Mandate

Vinge advises Doconomy in connection with its EUR 34 million Series B round

June 05, 2024

Vinge has advised Doconomy AB, a fintech start-up that provides banks with resources to promote financial health and climate action, in connection with its EUR 34 million Series B funding round. The round was led by UBS Next, the VC and innovation arm of UBS, and existing investor CommerzVentures, which acted as co-lead. Other shareholders who participated in the round include Motive Ventures, PostFinance and Tenity.

The funding will support Doconomy's product offering and expansion in North America, fostering broader adoption and engagement of the tools Doconomy provides.

Vinge's team consisted primarily of Jonas Johansson, Maria Dahlin Kolvik, Måns Håkansson and Ida Appelgren.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025